Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCORT
NCT06583889Active, not recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2024
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in cerebral venous sinus thrombosis (CVST) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Proportion with good prognosis at 90 days and Major intracranial and extracranial hemorrhagic complications at 7 days. Started Dec 2024; status: active, not recruiting.
02
Conditions
cerebral venous sinus thrombosis (CVST)
Beyond the preview
Go deeper on NCT06583889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06583889.